# MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

> **NCT05676489** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 28 (estimated)

## Conditions studied

- Healthy Volunteers
- Recurrent Glioma
- Brain Metastases From Extra-cranial Solid Tumors

## Interventions

- **DRUG:** [F-18]MeFAMP PET

## Key facts

- **NCT ID:** NCT05676489
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-04-01
- **Primary completion:** 2029-08-30
- **Final completion:** 2029-08-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05676489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05676489, "MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05676489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*